How to Address the Risk of HIV Transmission in Remission Studies With Treatment Interruption: The Low-Hanging Fruit Approach.
Where this comes from
- Record sourced from PubMed, PMID 31264692.
- Also identified by DOI 10.1093/infdis/jiz163 and PMC identifier 6603962.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Some HIV remission studies include a treatment interruption that seriously risks infecting participants' sex partners with HIV. What, ethically, is owed to these nonparticipants? Until greater certainty emerges on what protections should be afforded nonparticipants of research studies, what I call a "low-hanging fruit" approach may help researchers and review bodies determine how to address infection risks to nonparticipants in these studies.
Medical subject headings
- Anti-HIV Agents
- Coinfection
- HIV Infections
- Remission Induction
- Vaccines
- Withholding Treatment